Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
GREENVILLE, S.C., 22 avr. 2026 (GLOBE NEWSWIRE) -- MECART a annoncé aujourd’hui les résultats d’une analyse du cycle de vie (ACV), démontrant que ses systèmes de salles blanches présentent des...
-
Peer‑reviewed life cycle assessment shows MECART cleanroom systems have lower environmental impacts than the average North American cleanroom.
-
Bolstered leadership team positions Paratus to accelerate PS-1001 toward the clinic and build a pipeline of differentiated medicines.
-
Charlottesville, Virginia, April 22, 2026 (GLOBE NEWSWIRE) -- Luminoah, a medical technology company focused on modernizing enteral nutrition, today announced it has received U.S. Food and Drug...
-
GEVORKYAN, a.s. comunica che in data 22 aprile 2026 è entrata in vigore la transazione in seguito alla quale Gevorkyan Sinteris Italia S.r.l. ha acquisito tutte le attività dello stabilimento italiano...
-
GEVORKYAN, a.s. týmto informuje, že ku dňu 22. apríla 2026 nadobudla účinnosť transakcia, v dôsledku ktorej sa spoločnosť stala 100 % vlastníkom spoločnosti Gevorkyan Sinteris Italia S.r.l. so sídlom...
-
Společnost GEVORKYAN, a.s. tímto informuje, že ke dni 22. dubna 2026 nabyla účinnosti transakce, v jejímž důsledku se společnost stala 100% vlastníkem společnosti Gevorkyan Sinteris Italia S.r.l. se...
-
GEVORKYAN, a.s. hereby informs that, as of April 22, 2026, the transaction became effective, as a result of which the company became the 100% owner of Gevorkyan Sinteris Italia S.r.l., based in...
-
Cette nomination renforce la gouvernance d'Elkedonia alors que la société poursuit son développement et prépare ses prochaines étapes de croissancePierre d'Epenoux est l'ancien Président Directeur...
-
Appointment strengthens Elkedonia's governance as the company continues its development and prepares for its next phases of growthPierre d’Epenoux is former CEO of ImCheck Therapeutics, a...